Type 2 Diabetes Clinical Trial
Official title:
Effects of Red Grape Cells (RGC) Powder on Glycemic and Lipid Control in Patients With Type 2 Diabetes ¬ A Double-blind, Randomized, Placebo Controlled Study
The aim of this study is to examine whether the chronic administration during 12 weeks of polyphenols contained in Red Grape Cells (RGC) powder has an effect on mRNA expression of SIRT1 and Clock Genes, on circulating levels of HbA1c, lipids, blood pressure and on postprandial response of glucose, lipids, insulin, C-peptide and GLP-1 in patients with type 2 diabetes .
There is a growing body of evidence demonstrating that polyphenols and specially the most
investigated Resveratrol contained in the Red Grape Cells (RGC) exert beneficial effects on
several markers of metabolic syndrome i.e. antioxidant, anti-inflammatory,
anti-atherosclerotic, vasodilator and antihypertensive activity.
Many of this beneficial metabolic effects of polyphenols, occurs via activation of sirtuin-1
or silent information regulator-1 gene (SIRT1). This gene is expressed in adipose tissue,
muscle, endothelium, peripheral blood cells, etc where it plays a pivotal role in the
regulation of Circadian Clock Genes (CCG) involved in glucose lipid metabolism, endothelial
function, etc .
By activation of SIRT1 and CCG the polyphenols, may influence the circadian secretion of
adiponectin, insulin, asymmetric dimethylarginine (ADMA) and other hormones that influence
insulin sensitivity, muscular glucose uptake, NO synthesis, nocturnal hepatic glucose
production, lipolisis and endothelial function It was shown in several studies in animals and
in clinical studies in subjects with metabolic syndrome that SIRT1 expression and its
regulation of the CCG, improves insulin sensitivity in skeletal muscle, preventing weight
gain; improves pancreatic beta-cell function enhancing insulin secretion and glucose
tolerance. It was associated with increased lipolisis in white adipose tissue, decreased
glycolysis, increased fatty acid oxidation in skeletal muscle and with increase Nitric Oxide
in the endothelium.
Given that polyphenols directly on the clock genes or by enhancing SIRT1 expression appears
to counter some of the effects of a high-fat diet, obesity and metabolic syndrome, by
protecting against insulin resistance, hyperglycemia, and dyslipidemia and endothelial
dysfunction.
It rise the possibility that the polyphenols contained in Red Grape Cells (RGC) by activation
SIRT1 may also exert beneficial effects in subjects affected by type 2 diabetes
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |